Table 1.
List of solid-binding peptides featured in this review, listed per surface in alphabetical order. We report the amino acid sequences of short peptides (<30 residues), while longer peptides and domains are reported with their original nomenclature.
| Target | Sequence | Application | Reference |
|---|---|---|---|
| Gold | MHGKTQATSGTIQS | Theranostics, biosensing | [256,260,261,[265], [266], [267], [268], [269], [270]], first described in [50] |
| WALRRSIRRQSY | Theranostics | [257], first described in [333] | |
| ASHQWAWKWE | Theranostics | [258], first described in [255] | |
| LKAHLPPSRLPS | Biosensing | [262], first described in [334] | |
| WAGAKRLVLRRE | Biosensing | [271], first described in [333] | |
| AYSSGAPPMPPF | Material synthesis | [259], first described in [278] | |
| Graphene | HSSYWYAFNNKT | Biosensing | [327,329,330], first described in [335] |
| IMVTESSDYSSY | Biosensing | [328] | |
| HNWYHWWPH | Biocompatibility | [331], first described in [336] | |
| Hydroxyapatite | Poly(E) | Osteoinductivity, material synthesis, drug delivery | [[116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130],153,[155], [156], [157], [158],164,171,174,178] |
| Poly(D) | Osteoinductivity, drug delivery | [[131], [132], [133], [134],[170], [171], [172], [173],176,177,[179], [180], [181]] | |
| γEPRRγEVAγEL | Osteoinductivity | [[136], [137], [138], [139], [140], [141]], first described in [337] | |
| VTKHLNQISQSY | Osteoinductivity | [[142], [143], [144], [145], [146]], first described in [338] | |
| TKREEVD | Remineralization | [148,168] | |
| SYENSHSQAINVDRT | Remineralization | [149] | |
| TKRQQVV | Remineralization | [150] | |
| DRNLGDSLHRQEI | Remineralization | [151] | |
| KYKQKRRSYK | Remineralization | [152] | |
| DpSpSEEK | Remineralization | [153] | |
| CMLPHHGAC | Multi-material synthesis, biocompatibility, imaging | [154,[160], [161], [162],164,166,183] | |
| MSESDSSDSDSKS | Multi-material synthesis | [159,163] | |
| NNHYLPR | Biocompatibility | [165], first described in [339] | |
| SVSVGMKPSPRP | Biocompatibility | [167] | |
| (DSS)6 | Drug delivery | [175], first described in [340] | |
| STDKTKREEVD | Drug delivery | [182], first described in [341] | |
| KNFQSRSH | Imaging | [184] | |
| Polycaprolactone | LCI peptide (47 amino acids) | Material synthesis | [309,320], first described in [342,343] |
| Poly (chloro-p-xylylene) (Parylene C) | LCI peptide | Material synthesis | [323] |
| CecA peptide (37 amino acids) | Material synthesis | [323], first described in [344] | |
| Polydimethylsiloxane (PDMS) | LCI peptide | Biocompatibility | [318,345] |
| Poly (methyl methacrylate) (PMMA) | ELWRPTR | Biocompatibility | [317], first described in [346] |
| Poly (4-methylpentene) (PMP) | LCI peptide | Multi-material synthesis | [321,322,345] |
| Polystyrene | RIIIRRIRR | Biocompatibility | [316], first described in [347] |
| LCI peptide | Biocompatibility | [345] | |
| Polyurethane acrylate (PUA) | AIRGIRGIRGIR | Biocompatibility | [319] |
| Silica | RGRRRRLSCRLL | Drug delivery | [211], first described in [348] |
| SSKKSGSYSGSKGSKRRIL | Drug delivery, material synthesis, biosensing, biocompatibility | [[202], [203], [204],206,209,212,215,219,221,222,232,233,[236], [237], [238], [239]], first described in [349] | |
| L-linker (95 amino acids) | Drug delivery, biosensing | [213,214,[229], [230], [231]], first described in [350] | |
| RKKRKKRKKRKK | Drug delivery | [220], first described in [351,352] | |
| KPTHHHHHHDG | Material synthesis, drug delivery | [223], first described in [348] | |
| Si-tag (273 amino acids) | Biosensing, | [[226], [227], [228]], first described in [19] | |
| SSRSSSHRRHDHHDHRRGS | Biosensing, material synthesis, biocompatibility | [207,233], first described in [353] | |
| DSARGFKKPGKR | Biosensing | [234], first described in [354] | |
| MSPHPHPRHHHT | Biocompatibility | [208,209], first described in [348] | |
| Silver | NPSSLFRYLPSD | Nanoparticle synthesis, material synthesis | [275,285], first described in [278] |
| Ac-(3′-PyA)LRLRLRL (3′-PyA)-CONH2 | Material synthesis | [276] | |
| AYSSGAPPMPPF | Nanoparticle synthesis | [286], first described in [278] | |
| EQLGVRKELRGV | Biocompatibility, material synthesis | [287,288,290], first described in [355] | |
| WSWRSPTPHVVT | Antimicrobial material synthesis | [289], first described in [277] | |
| Titanium | DSSEE | Biocompatibility | [293], first described in [356] |
| RPRENRGRERGL | Biocompatibility | [294,295,[304], [305], [306], [307]] | |
| SRPNGYGGSESS | Biocompatibility | [294,304,305] | |
| CGHTHYHAVRTQT | Biocompatibility | [297], first described in [352] | |
| DYFSSPYYEQLF | Biocompatibility | [298], first described in [110,357] | |
| RKLPDA | Biocompatibility | [296,[299], [300], [301]], first described in [57] | |
| RKLPDAPGMHTW | Biocompatibility | [302,303], first described in [57] | |
| HAYKQPVLSTPF | Biocompatibility | [304] |